Skip to main content
    White folded printed paper on table in San Diego, California

    Do I Need a Lawyer for a Dangerous Drug Claim in San Diego?

    Free consultation with Ronald B. Laba. Call (760) 940-6231.

    Ronald B. LabaNovember 20, 2026
    Google Reviews
    5.0
    157 reviews

    “The Law office of Ronald B. Laba have helped me navigate the justice system through providing detailed explanations of the journey of the lawsuit Ron is helping through. Ron has always communicating what’s going on with my lawsuit step by step with my case made me feel at easy through a very difficult time assuring me that everything will be fine not to lose faith. I appreciate Ron and his team for being there for me and my family I would highly recommend Ron’s law firm”

    AH

    Anthony Hanna

    11 months ago

    By Ronald B. Laba, California attorney (State Bar No. 115846) · Updated November 20, 2026

    Reviewed by Ronald B. Laba, Attorney (Cal Bar 115846) on November 20, 2026

    Short answer

    We recommend an early legal review when you suspect a medication caused serious harm, especially if you are worried about deadlines. We can review your timeline, medication records, and potential warning issues. California’s general two-year injury deadline and discovery rule require careful attention to your circumstances. (CCP 335.1; Norgart v. Upjohn Co. (1999) 21 Cal.4th 383)

    Key takeaways

    • We start with timing: CCP 335.1 provides a general two-year limit for personal injury actions caused by another’s wrongful act or neglect.
    • We examine when you discovered or had reason to discover the claim; the discovery rule can postpone accrual. (Norgart v. Upjohn Co. (1999) 21 Cal.4th 383)
    • We recommend preserving medication packaging, pharmacy records, warning materials, and a dated account of symptoms and medical visits.
    • We distinguish prescription drugs from ordinary product-design claims: a manufacturer is not strictly liable for prescription-drug injuries when the drug was properly prepared and accompanied by adequate warnings of known or reasonably scientifically knowable dangers. (Brown v. Superior Court (1988) 44 Cal.3d 1049)
    • We evaluate potential failure-to-warn claims involving known or reasonably scientifically knowable prescription-drug risks. (Carlin v. Superior Court (1996) 13 Cal.4th 1104)

    Why We Recommend Reviewing Your Deadline Before Waiting for More Answers

    When a new health problem follows medication use, we understand why the first questions are medical: What happened, will the symptoms improve, and what treatment comes next? We recommend putting a deadline review alongside those questions rather than waiting until every medical issue has an answer. An initial conversation can help us identify important dates while you concentrate on care.

    California provides a two-year limitation period for an action for injury caused by another’s wrongful act or neglect under CCP 335.1. We do not treat that general rule as a ready-made filing date for every suspected drug injury. Understanding when the claim accrued requires attention to what happened and what you knew.

    The discovery rule postpones accrual until a person discovers, or has reason to discover, the cause of action. Suspicion, or reason to suspect, a factual basis for its elements matters under Norgart v. Upjohn Co. (1999) 21 Cal.4th 383. We therefore caution against assuming that the clock waits for a definitive medical explanation or a complete investigation.

    For example, we might hear from someone whose symptoms began during treatment but whose later appointment raised a possible connection to the medication. We would want both dates, along with any earlier conversations, messages, or records suggesting concern. We would not select the later appointment automatically or conclude that the first symptom necessarily controls.

    For an early review, we suggest gathering:

    • The approximate dates you started and stopped taking the medication.
    • When symptoms first appeared and when you sought treatment.
    • When anyone first discussed a possible medication-related injury.
    • Any correspondence already received about the suspected problem.

    We do not need a perfectly organized file to begin that conversation. If dates are uncertain, we would rather hear that uncertainty promptly than have you postpone contacting our office while searching for every document. Our immediate priority is understanding the timeline, not asking you to resolve the medical questions yourself.

    How We Apply California’s Two-Year Injury Limit and Discovery Rule

    We separate two questions when reviewing a potential deadline: which limitation period applies, and when that period began. Combining those questions too quickly can produce a misleading answer. A medication purchase date, first symptom, diagnosis, and discussion of a possible drug connection may occur at different times.

    Our starting point for an injury action based on another’s wrongful act or neglect is the two-year period in CCP 335.1. That statute supplies the general injury limitation period; we still need to examine the circumstances before identifying a filing deadline.

    We then consider the discovery rule explained in Norgart v. Upjohn Co. (1999) 21 Cal.4th 383. Under that decision, accrual is postponed until the plaintiff discovers, or has reason to discover, the cause of action—meaning at least suspecting, or having reason to suspect, a factual basis for its elements. We focus on the information available at the time, rather than only on what later testing revealed.

    In practical terms, we ask you to distinguish several events:

    1. Exposure: When you received and used the medication, including changes in dose.
    2. Symptoms: When you first noticed the problem and how it developed.
    3. Information: What clinicians or others told you about possible causes.
    4. Concern: When you first questioned whether the injury involved something wrong with the medication or its warnings.

    We also ask what prompted each concern. A dated message to a clinician may tell a different story from a general recollection that symptoms began sometime during treatment. We encourage you to label estimates as estimates and preserve the underlying records rather than trying to reconstruct a precise date from memory.

    Our advice is not to use the discovery rule as a reason to wait. Because suspicion and reason to suspect are part of the analysis under Norgart, we recommend discussing the earliest potentially relevant events. This overview is general California legal information; we would need your individual history to assess your deadline.

    What We Suggest Preserving While You Focus on Medical Care

    We recommend a manageable approach to gathering information after a suspected medication injury. Your immediate health concerns belong with your treating clinicians. We do not recommend changing or stopping prescribed treatment based on a legal article; we suggest asking your prescriber about medication decisions and seeking prompt medical attention for urgent symptoms.

    For our review, we suggest keeping the materials already available to you rather than attempting your own investigation. A labeled folder and a short timeline can provide a useful starting point. We would rather review an incomplete but accurate collection than a polished account that fills gaps with assumptions.

    • Medication identification: We suggest retaining containers, labels, packaging, pharmacy receipts, and any visible manufacturer or lot information.
    • Written information: We ask you to keep medication guides, instructions, and warning materials supplied with the prescription.
    • Treatment records: We suggest saving visit summaries, test results, discharge instructions, and patient-portal messages.
    • Communications: We ask you to preserve messages discussing symptoms, medication changes, or possible causes.
    • Daily observations: We suggest brief dated notes about symptoms and their effect on ordinary activities, without guessing at a diagnosis.

    We recommend photographing readable labels and keeping original electronic messages where possible. If medication remains, we suggest asking a pharmacist about safe storage or disposal rather than handling it unnecessarily. We do not want document preservation to create a health or household safety concern.

    Warning materials deserve attention because California recognizes a prescription-drug failure-to-warn claim involving known or reasonably scientifically knowable dangerous propensities under Carlin v. Superior Court (1996) 13 Cal.4th 1104. We would review the actual materials rather than assume what warnings accompanied your medication.

    We also encourage you to keep records from before the symptoms began. Earlier information can help us understand your baseline health and the treatment sequence. If you cannot locate something, we suggest listing the missing item and its possible source. We can discuss those gaps during an initial conversation; we do not ask you to delay reaching out until every record is collected.

    How We Evaluate the Medication, Symptoms, and Treatment Timeline

    We begin with the specific medication and the sequence of events, not with an assumption that symptoms following treatment establish a legal claim. We want to understand what you took, why it was prescribed, what changed, and what your clinicians have said. Our review separates your observations from medical conclusions and unanswered questions.

    We ask about the product name shown on the label, manufacturer information, dosage, refill history, and any substitutions. We also ask about other medications and health conditions. We use those details to organize the factual review, not to diagnose the cause of your symptoms.

    Next, we compare the medication history with the symptom and treatment history. For example, we might review a situation in which symptoms began after a refill, continued through several appointments, and were discussed as possibly medication-related only later. We would ask whether the product or dose changed, what records document each event, and what alternative explanations clinicians considered. We would not treat timing alone as an answer.

    California’s prescription-drug rules also shape our review. Under Brown v. Superior Court (1988) 44 Cal.3d 1049, a prescription-drug manufacturer is not strictly liable for design defect when the drug was properly prepared and accompanied by adequate warnings of dangers known or reasonably scientifically knowable at distribution. We therefore do not approach every adverse reaction as a design-defect claim.

    We separately examine warning questions. Carlin v. Superior Court (1996) 13 Cal.4th 1104 recognizes that a person injured by a prescription drug can state a strict liability failure-to-warn claim based on known or reasonably scientifically knowable dangerous propensities. We consider that distinction when reviewing the medication information and identifying what remains to be investigated.

    We recommend legal help when organizing these overlapping questions feels difficult, particularly while treatment continues or dates remain unclear. Our initial goal is to identify the deadline concerns, available records, and unresolved factual issues. We can discuss those matters without asking you to arrive with a proven diagnosis of the drug’s role or a completed legal theory.

    Why We Treat Prescription-Drug Design and Warning Issues Differently

    We begin a suspected prescription-drug injury review by separating two questions: what concerns exist about the medication itself, and what information accompanied it? We do not treat every serious reaction as proof that a manufacturer is legally responsible. Our review focuses on the particular medication, the alleged problem, and the evidence connecting that problem to the injury.

    California treats prescription-drug design claims differently from ordinary product-defect claims. In Brown v. Superior Court (1988) 44 Cal.3d 1049, the California Supreme Court held that a manufacturer is not strictly liable for injuries caused by a prescription drug when it was properly prepared and accompanied by warnings of dangerous propensities known or reasonably scientifically knowable at distribution. We therefore would not frame a claim simply as an argument that a medication could have been designed to avoid every risk.

    Warning issues require a separate inquiry. Under Carlin v. Superior Court (1996) 13 Cal.4th 1104, a person injured by a prescription drug may state a strict-liability failure-to-warn claim involving known or reasonably scientifically knowable dangerous propensities. We examine the available warning materials alongside the medication and treatment history rather than assuming that any warning either resolves or establishes a claim.

    For example, in a hypothetical review involving symptoms after a refill, we would want the original container, refill information, and materials supplied with both prescriptions. We would also ask whether the dosage changed, whether other medications changed, and what treating clinicians documented. Those questions organize our investigation; they are not conclusions about fault.

    We recommend keeping the distinction between design and warnings in mind when deciding whether to seek help. Our role is to identify which concerns deserve further investigation and explain the limits of the available evidence. We also review timing promptly, rather than waiting for every medical or warning-related question to be answered before considering a filing deadline.

    When We Recommend Legal Help With a Suspected Dangerous Drug Injury

    We recommend an early legal review when a suspected medication injury has interrupted treatment, required additional medical attention, or left you uncertain about what happened. We can begin with questions and incomplete records. Our initial task is to organize the facts and identify urgent issues, not to ask you to arrive with a fully developed legal theory.

    Timing deserves attention even while the medical picture is developing. CCP 335.1 provides a two-year limitation period for an action involving injury or death caused by another person's wrongful act or neglect. We do not use that general rule to assign a deadline without reviewing the circumstances.

    The discovery rule can affect when a claim accrues. Norgart v. Upjohn Co. (1999) 21 Cal.4th 383 explains that accrual is postponed until a person discovers, or has reason to discover, the cause of action—meaning at least a suspicion, or reason to suspect, a factual basis for its elements. We therefore ask about early concerns as well as later diagnoses; we do not assume that a recent confirmation necessarily supplies the starting date.

    We particularly encourage a conversation when:

    • You remember an earlier discussion about a possible medication-related injury but are unsure when it occurred.
    • Your treatment history involves several medications, changing dosages, or multiple prescribers.
    • You have received correspondence requesting a statement, signature, or response.
    • Your symptoms have made collecting records and tracking dates difficult.

    For a hypothetical reader who first noticed symptoms months before a clinician discussed a possible medication connection, we would review both events and the information available at each point. We would not select whichever date appears more favorable.

    Our practical recommendation is to seek advice before uncertainty becomes delay. We can discuss what needs investigation, what records may clarify the timeline, and whether representation makes sense after reviewing the information. We keep medical treatment decisions with your treating professionals and focus our review on the legal questions.

    What We Ask You to Bring to an Initial Consultation

    We would rather speak with you promptly than have you postpone a consultation while trying to assemble a perfect file. Bring what you already have, and tell us what is missing. We can use an initial conversation to identify the records and dates that deserve attention next.

    We suggest starting with the medication's identity. A photograph of the container may be useful if bringing it is impractical. We ask for the name printed on the label, dosage, manufacturer information if shown, prescription dates, and pharmacy records already in your possession. We also suggest preserving packaging, inserts, and written instructions without marking or discarding the originals.

    Our consultation checklist includes:

    • A brief timeline: When you began taking the medication, any dosage changes, when symptoms appeared, and when you first questioned a possible connection.
    • Medical documents: Visit summaries, discharge instructions, test results, and treatment recommendations you already have.
    • Other medication information: A list of prescriptions, nonprescription products, and supplements taken during the relevant period.
    • Communications: Messages with clinicians, the pharmacy, a manufacturer, or anyone contacting you about the suspected injury.
    • Daily-life notes: Specific examples of disrupted activities, missed work, and help you have needed.

    We ask you to distinguish remembered dates from dates confirmed by documents. If you are unsure whether a conversation happened before or after a refill, simply note the uncertainty. An honest gap is more useful than a guessed date presented as certain.

    We pay particular attention to when concerns first arose because Norgart v. Upjohn Co. (1999) 21 Cal.4th 383 ties discovery-rule accrual to discovery or reason to discover the factual basis of a claim. We use your chronology to explore that question, not to assume that your first symptom automatically started the period.

    We also invite you to bring a short list of questions. Our goal is to leave the discussion with a clearer understanding of your concerns, the available documents, and the next information needed for a meaningful review.

    How to Contact Our Office for a Free Consultation

    We invite you to call Law Offices of Ronald B. Laba, APC at (760) 940-6231 for a free consultation about a suspected dangerous drug injury. If your immediate concern is whether you have waited too long, mention that when you contact our office. We can begin by discussing the medication, the injury you suspect, and the dates you remember.

    We do not expect you to explain the difference between a design claim and a warning claim before speaking with us. We ask that you describe what happened in your own words: why you took the medication, what changed afterward, and what your treating professionals have told you. We can then identify questions for further review without treating your suspicions as established findings.

    Our attorney, Ronald B. Laba, has practiced since 1984 and holds California State Bar No. 115846. Our firm was founded in 1991. We approach an initial discussion as an opportunity to understand your situation and explain what information we need, rather than predict a result before reviewing the facts.

    You pay nothing unless we win. Fee details are discussed in person during your free consultation.

    When preparing to call, we suggest keeping three items nearby: the medication name, a rough timeline, and any correspondence that includes a response date. If those materials are unavailable, we still encourage you to reach out. We can discuss which details you know and which need confirmation.

    We also encourage prompt attention to timing. CCP 335.1 establishes the general two-year limit for injury actions based on another's wrongful act or neglect. We assess the relevant dates individually rather than suggesting that every medication-related injury follows an identical calendar.

    Our purpose in the consultation is to help you understand the questions ahead: what records to gather, what circumstances need investigation, and whether our office can assist. We can discuss those legal concerns while you continue addressing your health with your treating professionals. To begin that conversation, call our office at (760) 940-6231.

    Frequently asked questions

    What if my symptoms could have come from my underlying illness rather than the drug?

    We would approach that uncertainty directly, not assume that symptoms appearing after a prescription establish what caused them. Our review would compare your condition before treatment, the reason the medication was prescribed, changes in dosage, other medications, and the medical explanation for your later symptoms. We would also ask what your treating clinicians have said and whether additional testing is underway. California’s general tort-damages measure concerns detriment proximately caused by the wrongful conduct, under Cal. Civ. Code § 3333. That makes careful attention to the connection between the alleged problem and the harm important. We cannot resolve a medical question from timing alone. If the cause remains uncertain, we can discuss what information is missing without asking you to choose between medical care and an initial legal conversation.

    Can we handle a suspected drug injury claim for our child the same way as an adult claim?

    We would flag a child’s involvement immediately because representation and settlement procedures require separate attention. Cal. Code Civ. Proc. § 372 generally requires a minor party to appear through a guardian, conservator of the estate, or court-appointed guardian ad litem. Cal. Prob. Code § 3500 also provides that a qualifying parent’s compromise of a minor’s disputed claim is valid only after court approval. We would explain those requirements before treating any proposed resolution as complete. For the initial discussion, we would ask who cares for the child, whether any guardian has been appointed, and what medical records are available. We would also review deadlines individually rather than encourage a family to wait simply because the injured person is young. Our first conversation can begin before every record has been collected.

    Does a warning printed with my prescription mean there is nothing to investigate?

    We would not end our review merely because some warning appeared with the medication. Instead, we would examine the specific danger described, the warning language available at the relevant time, and the injury you experienced. Brown v. Superior Court (1988) 44 Cal.3d 1049 addresses prescription drugs that were properly prepared and accompanied by adequate warnings of known or reasonably scientifically knowable dangerous propensities. Carlin v. Superior Court (1996) 13 Cal.4th 1104 recognizes strict liability failure-to-warn claims concerning such risks. These decisions make the substance of the warning important, not just the existence of a printed insert. We suggest preserving the materials actually provided with your prescription. A current online version may not answer our questions about what information accompanied the medication when you received it.

    Does a medication recall automatically establish that I have a claim?

    We would review a recall notice as part of the investigation, rather than treat it as a conclusion about your individual claim. Our questions would include whether the notice identifies your medication, whether your prescription records match the product involved, and whether the concern described relates to your injury. For prescription-drug warning claims, Carlin v. Superior Court (1996) 13 Cal.4th 1104 recognizes a claim based on known or reasonably scientifically knowable dangerous propensities. That inquiry is different from simply asking whether a recall occurred. We suggest keeping any notice, packaging, and pharmacy correspondence together so we can compare them. We also would not recommend postponing a deadline review while waiting for a recall announcement; our assessment begins with your own history and available records.

    What should I do if someone offers a settlement before my medical outlook is clear?

    We suggest bringing the entire written proposal to our office before deciding whether to sign it. We would want to understand the injuries being addressed, the medical information still outstanding, and the claims the document purports to release. Cal. Civ. Code § 1542 states that a general release does not extend to claims the releasing party does not know or suspect to exist when signing and that would have materially affected the settlement if known. We would not treat that provision as a substitute for reading the actual document carefully. Our review would include its treatment of unknown injuries and any unanswered questions about your prognosis. We would also ask whether you received related letters or communications, because an isolated signature page does not give us enough context.

    Does living in San Diego County mean any lawsuit must be filed there?

    We would not select a filing location based solely on your current home address. Cal. Code Civ. Proc. § 395 generally identifies the county where the injury occurred or where a defendant resides when the action begins as proper venues for a personal injury action, subject to other applicable law and transfer authority. We would therefore ask where the relevant events occurred and identify the proposed defendants before advising you about venue. A medication history can involve prescribing, dispensing, and treatment in different places, so we would want the actual records rather than an assumption about geography. We can discuss the filing question during our assessment without requiring you to identify a courthouse yourself. Our focus would be on the facts that matter to the applicable venue analysis.

    Would my claim automatically become part of a group lawsuit involving the same drug?

    We would not assume that another lawsuit involving the same medication determines how your matter will proceed. We would first examine your individual records, the product involved, the alleged problem, and any existing proceedings you have heard about. Under Cal. Code Civ. Proc. § 404, a petition may seek coordination of civil actions sharing a common question of fact or law that are pending in different courts, subject to the statute’s requirements. That is a procedural possibility, not a reason for us to skip an individual assessment. We would explain any proposed coordination in relation to your particular matter. We also recommend bringing advertisements, letters, or notices mentioning other cases so we can identify what they actually describe rather than rely on a headline.

    Related questions

    Talk with our office

    Call (760) 940-6231 or send us a message for a free consultation. Learn more on our practice page, browse our learning center.

    Free Case Review

    Get your case evaluated at no cost

    No Win, No Fee
    5.0 Rating

    By submitting this form, you consent to be contacted by our law firm. Your information is confidential and protected.

    Prefer to talk?

    (760) 940-6231
    No Fee Unless We Win
    100% Contingency
    5,000+ Cases
    Successfully Handled
    Free Consultation
    Available 24/7
    Practicing Since 1984
    Experience
    Client Reviews

    What Our Clients Say

    Real testimonials from successful cases

    5.0

    "I wanted to take a moment to sincerely thank you for everything you did to..."

    Israel & April Romanabout 2 months ago
    Verified
    5.0

    "The Law office of Ronald B. Laba have helped me navigate the justice system through..."

    Anthony Hanna11 months ago
    Contact Us

    Get Your Free Consultation

    Don't wait to get the legal help you need. Contact us today for a free, no-obligation consultation about your personal injury case.

    Free Case Evaluation

    Get your case reviewed by an experienced attorney at no cost

    By submitting this form, you consent to be contacted by our law firm. Your information is confidential and protected.